About Me
Conditions and Treatments
Conditions
- acute myelogenous leukemia
- aids-related malignancies
- anemia
- bladder cancer
- central nervous system lymphoma
- chronic myelogenous leukemia (cml)
- cutaneous t-cell lymphoma
- diffuse large b-cell lymphoma
- essential thrombocythemia (et)
- female germ cell tumor
- hodgkin lymphoma
- kidney cancer
- male germ cell tumor
- multiple myeloma
- myelodysplastic syndromes (mds)
- myelofibrosis
- myeloproliferative disorder
- non-hodgkin lymphoma
- polycythemia vera
- prostate cancer
- sickle cell anemia
- testicular cancer
- thrombocytopenia
- thrombosis
- ureter cancer
Learn more about conditions we treat at NYU Langone:
Acute Myeloid Leukemia , Leukemia , AIDS-Related Lymphoma , Bladder Cancer , Primary Central Nervous System Lymphoma , Chronic Myelogenous Leukemia , Cutaneous T-Cell Lymphoma , Hodgkin Lymphoma , Kidney Cancer , Multiple Myeloma , Myelodysplastic Syndromes , Myeloproliferative Disorders , Non-Hodgkin Lymphoma , Prostate Cancer , Testicular CancerCredentials
Positions
- Clinical Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
- Site Director, Hematology and Medical Oncology Fellowship, Bellevue Cancer Center
- Director, Research, Bellevue Cancer Center
Board Certifications
- American Board of Internal Medicine (Medical Oncology), 2020
- American Board of Internal Medicine (Hematology), 2019
- American Board of Internal Medicine - Internal Medicine, 2017
Education and Training
- Fellowship, Montefiore Medical Center/Albert Einstein College of Medicine, Hematology & Medical Oncology, 2019
- Residency, Montefiore Medical Center/Albert Einstein College of Medicine, Internal Medicine, 2016
- PhD from SUNY - Stony Brook, 2008
- MD from Carol Davila University, 2003
Is this your profile?
Edit profileInsurance Plans Accepted
Please call the office for information about accepted insurance plans.
Cristian C. Papazoglu Statescu, MD, PhD does not accept insurance.
Research Academic Contact
Academic office
462 First Avenue, OBV-C&D Building
5th Floor, 556
New York, NY 10016
Phone
212-562-1135
Fax
212-263-8210
Clinical Trials and Research Studies
-
A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
-
A Phase 1b Multicenter Study to Determine the Dose Safety Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors
-
EMBER-4: A Randomized Open-Label Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+ HER2- Early Breast Cancer with an Increased Risk of Recurrence
Publications
-
Aminov, Sarah; Giricz, Orsi; Melnekoff, David T; Sica, R Alejandro; Polishchuk, Veronika; Papazoglu, Cristian; Yates, Bonnie; Wang, Hao-Wei; Sahu, Srabani; Wang, Yanhua; Gordon-Mitchell, Shanisha; Leshchenko, Violetta V; Schinke, Carolina; Pradhan, Kith; Aluri, Srinivas; Sohn, Moah; Barta, Stefan K; Agarwal, Beamon; Goldfinger, Mendel; Mantzaris, Ioannis; Shastri, Aditi; Matsui, William; Steidl, Ulrich; Brody, Joshua D; Shah, Nirali N; Parekh, Samir; Verma, Amit
Journal of clinical investigation. 2024 Feb 20; 134(8):
-
Bhatt, Ahan; Papazoglu, Cristian; Shukla, Pratibha
Journal of Clinical Oncology. 2023; 41(16_suppl):
-
Zhang, Hailan; Fraser, Stuart T; Papazoglu, Cristian; Hoatlin, Maureen E; Baron, Margaret H
Stem cells. 2009 Dec ; 27(12):2884-95